Skip to main content
AETHLON MEDICAL INC logo

AETHLON MEDICAL INC — Investor Relations & Filings

Ticker · AEMD ISIN · US00808Y3071 LEI · 54930036LMXCIW3XG337 US Manufacturing
Filings indexed 1,002 across all filing types
Latest filing 2026-03-17 Regulatory Filings
Country US United States of America
Listing US AEMD

About AETHLON MEDICAL INC

https://www.aethlonmedical.com/

Aethlon Medical, Inc. is a medical therapeutic company focused on developing immunotherapeutic devices. Its principal product is the Hemopurifier®, a clinical-stage, first-in-class medical device designed for the rapid depletion of cancer-promoting exosomes and life-threatening viruses from the blood. The Hemopurifier® has received "Breakthrough Device" designation from the U.S. Food and Drug Administration (FDA) for two indications: the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard care, and for life-threatening viruses that are not addressed with approved therapies.

Recent filings

Filing Released Lang Actions
8-K - AETHLON MEDICAL INC (0000882291) (Filer)
Regulatory Filings
2026-03-17 English
8-K - AETHLON MEDICAL INC (0000882291) (Filer)
Regulatory Filings
2026-02-23 English
SCHEDULE 13G - AETHLON MEDICAL INC (0000882291) (Subject)
Major Shareholding Notification
2026-02-18 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-02-18 English
8-K - AETHLON MEDICAL INC (0000882291) (Filer)
Regulatory Filings
2026-02-12 English
10-Q Filing
Interim / Quarterly Report Q3 2026
2026-02-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.